NEW YORK: Hill & Knowlton has hired AnnaMaria DeSalva, former worldwide managing director of GCI Healthcare, as director of its worldwide healthcare practice, effective October 1.
New York-based DeSalva will join H&K's worldwide executive committee and report to Paul Taaffe, chairman and CEO. DeSalva joined GCI in May 2002, after spending five years at Bristol-Myers Squibb, in the international public affairs and strategic philanthropy departments.
"H&K has such strength, historically, in corporate affairs, pub affairs, and technology," DeSalva said. "It really seemed like an appropriate platform to do the work I love to do and grow in these new directions."
DeSalva said the agency's healthcare offering will tap resources from other disciplines, underscoring the complex landscape in which it inhabits.
"We're [not just] talking about the marketing of pharma products, we're talking about technology adoption and healthcare financing," DeSalva said. "You begin to see the potential if you create a bigger point of intersection between healthcare and tech; healthcare and corporate."
DeSalva "will have the widespread support of the firm to apply our diverse resources to the unique problems and opportunities facing organizations involved in improving human health," Taaffe said, via a release.
"Problems in healthcare are complicated and typically require an interdisciplinary strategy," DeSalva said. "When you're trying to reach a diverse group of stakeholders, you need different insights into different sectors. I'm excited because H&K has breadth in other disciplines beyond classic healthcare marketing."
GCI Group last week announced that Bill Martin had been named EVP, North American practice leader, a newly created position, and Jill Dosik has been named EVP, director, New York Healthcare. GCI is not currently looking for someone to replace DeSalva.